Table 2.
Participants’ lifetime occasions of recreational drug use
| AMP group (n) |
THC group (n) |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Never | 1–10 | 11–50 | 51–100 | 100+ | Never | 1–10 | 11–50 | 51–100 | 100+ | |
| Cannabis | 0 | 1 | 7 | 6 | 11 | 0 | 0 | 10 | 1 | 14 |
| Sedativesa | 21 | 4 | 0 | 0 | 0 | 17 | 5 | 2 | 1 | 0 |
| Stimulantsb | 14 | 7 | 3 | 0 | 1 | 10 | 5 | 5 | 2 | 3 |
| Opioidsc | 20 | 5 | 0 | 0 | 0 | 9 | 9 | 4 | 3 | 0 |
| Hallucinogensd | 10 | 14 | 1 | 0 | 0 | 10 | 8 | 4 | 0 | 3 |
| Inhalantse | 23 | 2 | 0 | 0 | 0 | 18 | 5 | 2 | 0 | 0 |
a
e.g., diazepam, alprazolam, clonazepam
b
e.g., amphetamine, methylphenidate, cocaine, methamphetamine
c
e.g., codeine, morphine, oxycodone, heroin, opium
d
e.g., lysergic acid diethylamide, psilocybin, mescaline, ±3,4-methylenedioxymethamphetamine
e
e.g., nitrous oxide, amyl nitrite